| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |